{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T06:09:27Z","timestamp":1791958167787,"version":"4.3.4"},"reference-count":12,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2013,10,23]],"date-time":"2013-10-23T00:00:00Z","timestamp":1382486400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplant Infectious Dis"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We report a patient with an autologous stem cell transplant and history of residence in a Chagas disease (<jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>) endemic area who developed Chagas reactivation after induction for transplantation. We recommend that patients at risk for <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content> be screened before transplantation, and patients found to have chronic infection be monitored for reactivation post transplant.<\/jats:p>","DOI":"10.1111\/tid.12157","type":"journal-article","created":{"date-parts":[[2013,10,23]],"date-time":"2013-10-23T07:40:52Z","timestamp":1382514052000},"source":"Crossref","is-referenced-by-count":24,"title":["Reactivation of <scp>C<\/scp>hagas disease in a bone marrow transplant patient: case report and review of screening and management"],"prefix":"10.1111","volume":"15","author":[{"given":"K.M.U.","family":"Guiang","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases University of Southern California Keck School of Medicine Los Angeles California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Cantey","sequence":"additional","affiliation":[{"name":"Division of Parasitic Diseases and Malaria Center for Global Health Centers for Disease Control and Prevention Atlanta Georgia USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.P.","family":"Montgomery","sequence":"additional","affiliation":[{"name":"Division of Parasitic Diseases and Malaria Center for Global Health Centers for Disease Control and Prevention Atlanta Georgia USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Ailawadhi","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology University of Southern California Norris Comprehensive Cancer Center Los Angeles California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Qvarnstrom","sequence":"additional","affiliation":[{"name":"Division of Parasitic Diseases and Malaria Center for Global Health Centers for Disease Control and Prevention Atlanta Georgia USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Price","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology University of Southern California Norris Comprehensive Cancer Center Los Angeles California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Blodget","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases University of Southern California Keck School of Medicine Los Angeles California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,10,23]]},"reference":[{"key":"e_1_2_5_2_1","volume-title":"International Standards for Cellular Therapy Product Collection, Processing, and Administration. FACT\u2010JACIE International Standards Accreditation Manual","author":"The Foundation for the Accreditation of Cellular Therapy and the Joint Accreditation Committee \u2013 ISCT and EMBT","year":"2008"},{"key":"e_1_2_5_3_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001689"},{"key":"e_1_2_5_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2007.01820.x"},{"key":"e_1_2_5_5_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001277"},{"key":"e_1_2_5_6_1","doi-asserted-by":"publisher","DOI":"10.1086\/605091"},{"key":"e_1_2_5_7_1","doi-asserted-by":"publisher","DOI":"10.1086\/598634"},{"key":"e_1_2_5_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705006"},{"key":"e_1_2_5_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0b013e328354f179"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.298.18.2171"},{"key":"e_1_2_5_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2012.03569.x"},{"key":"e_1_2_5_12_1","volume-title":"Guidance for Industry: Eligibility Determination for Donors of Human Cells, Tissues, and Cellular and Tissue\u2010Based Products (HCT\/Ps)","author":"US Food and Drug Administration","year":"2007"},{"key":"e_1_2_5_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2011.03444.x"}],"container-title":["Transplant Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Ftid.12157","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/tid.12157","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T11:38:10Z","timestamp":1695987490000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/tid.12157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,23]]},"references-count":12,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["10.1111\/tid.12157"],"URL":"https:\/\/doi.org\/10.1111\/tid.12157","archive":["Portico"],"relation":{},"ISSN":["1398-2273","1399-3062"],"issn-type":[{"value":"1398-2273","type":"print"},{"value":"1399-3062","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,23]]}}}